pirenzepine has been researched along with Hyperinsulinism in 2 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Hyperinsulinism: A syndrome with excessively high INSULIN levels in the BLOOD. It may cause HYPOGLYCEMIA. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor (INSULINOMA); autoantibodies against insulin (INSULIN ANTIBODIES); defective insulin receptor (INSULIN RESISTANCE); or overuse of exogenous insulin or HYPOGLYCEMIC AGENTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The primary objective of this study was to evaluate insulin sensitivity in healthy subjects treated with olanzapine or risperidone." | 9.10 | Evaluation of insulin sensitivity in healthy volunteers treated with olanzapine, risperidone, or placebo: a prospective, randomized study using the two-step hyperinsulinemic, euglycemic clamp. ( Breier, A; Carlson, C; Cavazzoni, P; Chinnapongse, S; Dananberg, J; Davis, T; Henry, RR; Mudaliar, S; Mukhopadhyay, N; Ray, A; Sowell, M, 2003) |
| "The primary objective of this study was to evaluate insulin sensitivity in healthy subjects treated with olanzapine or risperidone." | 5.10 | Evaluation of insulin sensitivity in healthy volunteers treated with olanzapine, risperidone, or placebo: a prospective, randomized study using the two-step hyperinsulinemic, euglycemic clamp. ( Breier, A; Carlson, C; Cavazzoni, P; Chinnapongse, S; Dananberg, J; Davis, T; Henry, RR; Mudaliar, S; Mukhopadhyay, N; Ray, A; Sowell, M, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sowell, M | 1 |
| Mukhopadhyay, N | 1 |
| Cavazzoni, P | 1 |
| Carlson, C | 1 |
| Mudaliar, S | 1 |
| Chinnapongse, S | 1 |
| Ray, A | 1 |
| Davis, T | 1 |
| Breier, A | 1 |
| Henry, RR | 1 |
| Dananberg, J | 1 |
| Cohn, TA | 1 |
| Remington, G | 1 |
| Kameh, H | 1 |
1 trial available for pirenzepine and Hyperinsulinism
| Article | Year |
|---|---|
Evaluation of insulin sensitivity in healthy volunteers treated with olanzapine, risperidone, or placebo: a prospective, randomized study using the two-step hyperinsulinemic, euglycemic clamp.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Weight; Fasting; Fatty Acids, None | 2003 |
1 other study available for pirenzepine and Hyperinsulinism
| Article | Year |
|---|---|
Hyperinsulinemia in psychiatric patients treated with olanzapine.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Fasting; Female; Humans; Hyperinsulinis | 2002 |